TERAPET is a Swiss start-up founded by two former CERN physicists and a leading oncologist from Geneva University Hospitals.
The purpose of TERAPET is to develop and commercialise innovative solutions for a safer, more precise and time-saving proton therapy for cancer treatment. Its solutions enable medical doctors to monitor the delivered proton dose inside the patients during cancer treatment in 3D, in real time, in-vivo and in a non-invasive way. By doing so, doctors will precisely know the actual dose received by every patient during every session.
TERAPET entered the Swiss BIC of CERN Technologies in 2020. In February 2021, TERAPET and CERN started an Innovation Project funded by Innosuisse, that supports the development of Terapet’s first full-scale prototype.